Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $2.09 billion. The enterprise value is $2.31 billion.
| Market Cap | 2.09B |
| Enterprise Value | 2.31B |
Important Dates
The last earnings date was Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 79.32 million shares outstanding. The number of shares has decreased by -1.21% in one year.
| Current Share Class | 79.32M |
| Shares Outstanding | 79.32M |
| Shares Change (YoY) | -1.21% |
| Shares Change (QoQ) | -2.00% |
| Owned by Insiders (%) | 1.64% |
| Owned by Institutions (%) | 106.59% |
| Float | 77.98M |
Valuation Ratios
The trailing PE ratio is 12.32 and the forward PE ratio is 11.01.
| PE Ratio | 12.32 |
| Forward PE | 11.01 |
| PS Ratio | 1.08 |
| Forward PS | 1.06 |
| PB Ratio | 2.39 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.22 |
| P/OCF Ratio | 8.53 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.81, with an EV/FCF ratio of 10.16.
| EV / Earnings | 13.29 |
| EV / Sales | 1.19 |
| EV / EBITDA | 8.81 |
| EV / EBIT | 9.65 |
| EV / FCF | 10.16 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.70.
| Current Ratio | 1.32 |
| Quick Ratio | 1.28 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 2.25 |
| Debt / FCF | 2.71 |
| Interest Coverage | 7.05 |
Financial Efficiency
Return on equity (ROE) is 20.39% and return on invested capital (ROIC) is 16.34%.
| Return on Equity (ROE) | 20.39% |
| Return on Assets (ROA) | 7.11% |
| Return on Invested Capital (ROIC) | 16.34% |
| Return on Capital Employed (ROCE) | 14.78% |
| Weighted Average Cost of Capital (WACC) | 7.02% |
| Revenue Per Employee | $455,754 |
| Profits Per Employee | $40,843 |
| Employee Count | 4,280 |
| Asset Turnover | 0.92 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MD has paid $51.41 million in taxes.
| Income Tax | 51.41M |
| Effective Tax Rate | 22.73% |
Stock Price Statistics
The stock price has increased by +59.38% in the last 52 weeks. The beta is 0.65, so MD's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +59.38% |
| 50-Day Moving Average | 25.61 |
| 200-Day Moving Average | 22.69 |
| Relative Strength Index (RSI) | 45.82 |
| Average Volume (20 Days) | 753,232 |
Short Selling Information
The latest short interest is 4.14 million, so 5.22% of the outstanding shares have been sold short.
| Short Interest | 4.14M |
| Short Previous Month | 3.80M |
| Short % of Shares Out | 5.22% |
| Short % of Float | 5.31% |
| Short Ratio (days to cover) | 5.52 |
Income Statement
In the last 12 months, MD had revenue of $1.95 billion and earned $174.81 million in profits. Earnings per share was $2.10.
| Revenue | 1.95B |
| Gross Profit | 511.77M |
| Operating Income | 240.65M |
| Pretax Income | 226.22M |
| Net Income | 174.81M |
| EBITDA | 263.74M |
| EBIT | 240.65M |
| Earnings Per Share (EPS) | $2.10 |
Balance Sheet
The company has $404.20 million in cash and $619.96 million in debt, with a net cash position of -$215.76 million or -$2.72 per share.
| Cash & Cash Equivalents | 404.20M |
| Total Debt | 619.96M |
| Net Cash | -215.76M |
| Net Cash Per Share | -$2.72 |
| Equity (Book Value) | 880.98M |
| Book Value Per Share | 11.11 |
| Working Capital | 158.56M |
Cash Flow
In the last 12 months, operating cash flow was $246.86 million and capital expenditures -$18.25 million, giving a free cash flow of $228.61 million.
| Operating Cash Flow | 246.86M |
| Capital Expenditures | -18.25M |
| Depreciation & Amortization | 23.08M |
| Net Borrowing | -23.83M |
| Free Cash Flow | 228.61M |
| FCF Per Share | $2.88 |
Margins
Gross margin is 26.24%, with operating and profit margins of 12.34% and 8.96%.
| Gross Margin | 26.24% |
| Operating Margin | 12.34% |
| Pretax Margin | 11.60% |
| Profit Margin | 8.96% |
| EBITDA Margin | 13.52% |
| EBIT Margin | 12.34% |
| FCF Margin | 11.72% |
Dividends & Yields
MD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.21% |
| Shareholder Yield | 1.21% |
| Earnings Yield | 8.30% |
| FCF Yield | 10.85% |
Analyst Forecast
The average price target for MD is $26.33, which is -0.25% lower than the current price. The consensus rating is "Hold".
| Price Target | $26.33 |
| Price Target Difference | -0.25% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 3.15% |
| EPS Growth Forecast (3Y) | 5.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 20, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 20, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
MD has an Altman Z-Score of 2.16 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.16 |
| Piotroski F-Score | 6 |